Menu visibility control

Video

Events

Startup Surgery

Most Recent

News

Top tech stats: Job automation, driverless cars and much more

News

Startup Weekly: Nesta’s £5m prize fund, Digital Catapult and Seedcamp’s VR cohort and much more

Investments

FinTech startup Quantexa lands $3.3m Series A led by Albion Ventures and HSBC

Press Releases

Starling Bank unveils beta as it begins roll out to first customers
VentureFounders surpasses £40m funding mark in 2 years of operation
Software testing leader TestPlant appoints Dr. John Bates as CEO

Cambridge-based Healx secures £1.5m Series A to combat rare diseases

medication
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

HealthTech startup Healx has secured a £1.5m Series A round from Amadeus Capital and Jonathan Milner, a healthcare entrepreneur.

The Cambridge-based firm, which uses machine learning and advanced data analytics, seeks to find new uses for existing drugs in an attempt to combat rare diseases.

Hermann Hauser, partner and co-founder of Amadeus Capital Partners, said: “Healx has taken advances in machine learning, data mining and analytics and combined them with deep pharma and life sciences expertise to address a growing need in the healthcare sector.

October funding roundup: UK tech investment tops £130m

“With huge pressure on R&D budgets, drug repositioning will be essential in the fight against rare diseases,” he added.

Healx’s technology platform matches potential treatments to rare conditions and patients. The company aims to complete its drug repurposing studies within six months.

Tim Guilliams, founder & CEO at Healx, commented: “Studies into rare medical conditions have long failed to receive adequate funding.”

The firm says it will use the money to expand its technology platform and accelerate the drug review process, in hope to find treatments to more illnesses.

“By repurposing existing drugs to combat rare diseases, Healx is able to find potential treatments at a fraction of the cost and in a much shorter timeframe than developing a new drug,” Guilliams concluded.

Enter your e-mail address to receive updates straight to your inbox

* indicates required
Send me news on...
twitterlinkedinFacebookgoogle_plustwitterlinkedinFacebookgoogle_plus

Editor's picks

jobs automation top tech stats

Top tech stats: Job automation, driverless cars and much more
posted 6 hours ago

Startup Weekly

Startup Weekly: Nesta’s £5m prize fund, Digital Catapult and Seedcamp’s VR cohort and much more
posted on March 24, 2017

London skyline

FinTech startup Quantexa lands $3.3m Series A led by Albion Ventures and HSBC
posted on March 24, 2017

The North of England

The top tech hubs in the North of England
posted on March 24, 2017

TWIT Emily 23.03.17

A $30.4m Series B, a £120m AI fund, a Mario Kart hack and more in The Week in Tech
posted on March 24, 2017

Tech and banking

How tech is shaking up the world of banking
posted on March 23, 2017